Literature DB >> 9316504

Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease.

J A Martinez1, T E King, K Brown, C A Jennings, L Borish, R L Mortenson, T Z Khan, T W Bost, D W Riches.   

Abstract

Idiopathic pulmonary fibrosis (IPF) and bronchiolitis obliterans with organizing pneumonia (BOOP) are interstitial lung diseases of unknown pathogenesis. Alveolar macrophages play a major role in the regulation of the inflammatory response in these diseases through their ability to produce cytokines that modify the inflammatory response. Tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) exhibit proinflammatory and anti-inflammatory actions, respectively, and thus an imbalance in the expression of these cytokines may contribute to the pathogenesis of IPF and BOOP. Therefore, we quantified IL-10 and TNF-alpha mRNA levels in alveolar macrophages obtained by bronchoalveolar lavage (BAL) from patients with IPF and BOOP and in normal healthy volunteers. The level of TNF-alpha mRNA in macrophages obtained from IPF and BOOP patients was not significantly different from normal healthy subjects. However, macrophages from patients with IPF and BOOP expressed increased levels of IL-10 mRNA compared with healthy controls. In addition, stimulation of alveolar macrophages with lipopolysaccharide in the presence of a neutralizing anti-IL-10 antibody augmented the production of TNF-alpha over that seen in the absence of anti-IL-10 antibody, suggesting that the increased expression of IL-10 by alveolar macrophages may act to control the expression of TNF-alpha. Paradoxically, measurement of IL-10 protein in cell-free BAL fluid revealed lower amounts of the protein in patients with IPF and BOOP compared with healthy controls.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9316504     DOI: 10.1152/ajplung.1997.273.3.L676

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  24 in total

Review 1.  Lung fibrosis.

Authors:  C Fonseca; D Abraham; C M Black
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Structure and function of interleukin-22 and other members of the interleukin-10 family.

Authors:  Daniela Barretto Barbosa Trivella; José Ribamar Ferreira-Júnior; Laure Dumoutier; Jean-Christophe Renauld; Igor Polikarpov
Journal:  Cell Mol Life Sci       Date:  2010-05-08       Impact factor: 9.261

3.  Expression of the immunomodulator IL-10 in type I pneumocytes of the rat: alterations of IL-10 expression in radiation-induced lung damage.

Authors:  Michael G Haase; Anke Klawitter; Peter Geyer; Gustavo B Baretton
Journal:  J Histochem Cytochem       Date:  2007-08-06       Impact factor: 2.479

4.  TNF-alpha sensitizes normal and fibrotic human lung fibroblasts to Fas-induced apoptosis.

Authors:  Stephen K Frankel; Gregory P Cosgrove; Seung-Ick Cha; Carlyne D Cool; Murry W Wynes; Benjamin L Edelman; Kevin K Brown; David W H Riches
Journal:  Am J Respir Cell Mol Biol       Date:  2005-11-04       Impact factor: 6.914

5.  IL-10: Another therapeutic target in idiopathic pulmonary fibrosis?

Authors:  A B Millar
Journal:  Thorax       Date:  2006-10       Impact factor: 9.139

6.  Mechanism of fibroblast inflammatory responses to Pseudomonas aeruginosa elastase.

Authors:  Ali O Azghani; Kourtney Neal; Steven Idell; Rodolfo Amaro; Jason W Baker; Abdelwahab Omri; Usha R Pendurthi
Journal:  Microbiology (Reading)       Date:  2014-01-02       Impact factor: 2.777

7.  In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-beta in the lung.

Authors:  K Nakagome; M Dohi; K Okunishi; R Tanaka; J Miyazaki; K Yamamoto
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

8.  Tissue and Bronchoalveolar Lavage Biomarkers in Idiopathic Pulmonary Fibrosis Patients on Pirfenidone.

Authors:  Nicola Ronan; Deirdre M Bennett; Kashif A Khan; Yvonne McCarthy; Darren Dahly; Louise Bourke; Adeline Chelliah; Alberto Cavazza; Kevin O'Regan; Fiachra Moloney; Barry J Plant; Michael T Henry
Journal:  Lung       Date:  2018-07-31       Impact factor: 2.584

9.  Hydrogel-based delivery of Il-10 improves treatment of bleomycin-induced lung fibrosis in mice.

Authors:  Elya A Shamskhou; Michael J Kratochvil; Mark E Orcholski; Nadine Nagy; Gernot Kaber; Emily Steen; Swathi Balaji; Ke Yuan; Sundeep Keswani; Ben Danielson; Max Gao; Carlos Medina; Abinaya Nathan; Ananya Chakraborty; Paul L Bollyky; Vinicio A De Jesus Perez
Journal:  Biomaterials       Date:  2019-02-22       Impact factor: 12.479

10.  Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.

Authors:  Alison Bamberg; Elizabeth F Redente; Steve D Groshong; Rubin M Tuder; Carlyne D Cool; Rebecca C Keith; Benjamin L Edelman; Bart P Black; Gregory P Cosgrove; Murry W Wynes; Douglas Curran-Everett; Stijn De Langhe; Luis A Ortiz; Andrew Thorburn; David W H Riches
Journal:  Am J Respir Crit Care Med       Date:  2018-10-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.